Insurance-driven rheumatology care is increasingly fragmented, characterized by 3–6 month wait times, administrative burdens, and opaque cost structures that limit timely interventions for autoimmune disease. Direct Specialty Care (DSC) offers a sustainable alternative by providing expedited access, extended consultations, price transparency, and longitudinal continuity with a single rheumatologist. This model realigns incentives toward patient outcomes, enabling earlier treatment initiation, improved disease control, and higher patient satisfaction.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.